Vericel Corp. (VCEL)
36.01
-0.72
(-1.96%)
USD |
NASDAQ |
Dec 31, 16:00
36.00
0.00 (0.00%)
Pre-Market: 20:00
Vericel Total Liabilities (Quarterly): 131.42M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 137.50M |
| Vanda Pharmaceuticals, Inc. | 135.14M |
| Marker Therapeutics, Inc. | 3.346M |
| Veracyte, Inc. | 110.12M |
| Aldeyra Therapeutics, Inc. | 28.56M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 453.27M |
| Shareholders Equity (Quarterly) | 321.86M |
| Debt to Equity Ratio | 0.3101 |
| Current Ratio | 4.870 |
| Net Debt Paydown Yield | -0.05% |